世界における卵巣がん検査製品のパイプライン動向2015...市場調査レポートについてご紹介

【英文タイトル】Ovarian Cancer - Pipeline Review, 2015

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 14
2 Introduction 15
2.1 Ovarian Cancer Overview 15
3 Products under Development 16
3.1 Ovarian Cancer – Pipeline Products by Stage of Development 16
3.2 Ovarian Cancer – Pipeline Products by Territory 17
3.3 Ovarian Cancer – Pipeline Products by Regulatory Path 18
3.4 Ovarian Cancer – Pipeline Products by Estimated Approval Date 19
3.5 Ovarian Cancer – Ongoing Clinical Trials 20
4 Ovarian Cancer – Pipeline Products under Development by Companies 21
4.1 Ovarian Cancer Companies – Pipeline Products by Stage of Development 21
4.2 Ovarian Cancer – Pipeline Products by Stage of Development 25
5 Ovarian Cancer Companies and Product Overview 29
5.1 A&G Pharmaceutical, Inc. Company Overview 29
5.1.1 A&G Pharmaceutical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 29
5.2 Abcodia Ltd. Company Overview 31
5.2.1 Abcodia Ltd. Pipeline Products & Ongoing Clinical Trials Overview 31
5.3 Abnova Corporation Company Overview 32
5.3.1 Abnova Corporation Pipeline Products & Ongoing Clinical Trials Overview 32
5.4 Adaptive Biotechnologies Corporation Company Overview 34
5.4.1 Adaptive Biotechnologies Corporation Pipeline Products & Ongoing Clinical Trials Overview 34
5.5 Almac Diagnostics Limited Company Overview 35
5.5.1 Almac Diagnostics Limited Pipeline Products & Ongoing Clinical Trials Overview 35
5.6 AroCell AB Company Overview 36
5.6.1 AroCell AB Pipeline Products & Ongoing Clinical Trials Overview 36
5.7 Arrayit Diagnostics, Inc. Company Overview 37
5.7.1 Arrayit Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 37
5.8 ArtemixRx Company Overview 39
5.8.1 ArtemixRx Pipeline Products & Ongoing Clinical Trials Overview 39
5.9 Aurelium BioPharma Inc. (Inactive) Company Overview 40
5.9.1 Aurelium BioPharma Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 40
5.10 Axela Inc. Company Overview 42
5.10.1 Axela Inc. Pipeline Products & Ongoing Clinical Trials Overview 42
5.11 Ayanda Biosystems S.A. Company Overview 43
5.11.1 Ayanda Biosystems S.A. Pipeline Products & Ongoing Clinical Trials Overview 43
5.12 Becton, Dickinson and Company Company Overview 44
5.12.1 Becton, Dickinson and Company Pipeline Products & Ongoing Clinical Trials Overview 44
5.13 Bioindustry Park Silvano Fumero S.p.A. Company Overview 46
5.13.1 Bioindustry Park Silvano Fumero S.p.A. Pipeline Products & Ongoing Clinical Trials Overview 46
5.14 BioMark Diagnostics Inc. Company Overview 47
5.14.1 BioMark Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview 47
5.15 Ceres Nanosciences, Inc. Company Overview 48
5.15.1 Ceres Nanosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 48
5.16 Chronix Biomedical, Inc. Company Overview 50
5.16.1 Chronix Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 50
5.17 Clarient, Inc. Company Overview 52
5.17.1 Clarient, Inc. Pipeline Products & Ongoing Clinical Trials Overview 52
5.18 ClavGen Therapeutics LLC Company Overview 53
5.18.1 ClavGen Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview 53
5.19 Cleveland Diagnostics Inc. Company Overview 54
5.19.1 Cleveland Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview 54
5.20 Clovis Oncology, Inc. Company Overview 55
5.20.1 Clovis Oncology, Inc. Pipeline Products & Ongoing Clinical Trials Overview 55
5.21 Cornell University Company Overview 57
5.21.1 Cornell University Pipeline Products & Ongoing Clinical Trials Overview 57
5.22 Courtagen Life Sciences, Inc. Company Overview 58
5.22.1 Courtagen Life Sciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 58
5.23 CS-Keys, Inc. Company Overview 59
5.23.1 CS-Keys, Inc. Pipeline Products & Ongoing Clinical Trials Overview 59
5.24 Dako A/S Company Overview 60
5.24.1 Dako A/S Pipeline Products & Ongoing Clinical Trials Overview 60
5.25 Dana-Farber Cancer Institute, Inc. Company Overview 61
5.25.1 Dana-Farber Cancer Institute, Inc. Pipeline Products & Ongoing Clinical Trials Overview 61
5.26 diaDexus, Inc. Company Overview 62
5.26.1 diaDexus, Inc. Pipeline Products & Ongoing Clinical Trials Overview 62
5.27 Eventus Diagnostics, Inc. Company Overview 67
5.27.1 Eventus Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 67
5.28 Exiqon A/S Company Overview 68
5.28.1 Exiqon A/S Pipeline Products & Ongoing Clinical Trials Overview 68
5.29 Exosomics Siena SpA Company Overview 70
5.29.1 Exosomics Siena SpA Pipeline Products & Ongoing Clinical Trials Overview 70
5.30 Foundation Medicine, Inc. Company Overview 71
5.30.1 Foundation Medicine, Inc. Pipeline Products & Ongoing Clinical Trials Overview 71
5.31 Ganymed Pharmaceuticals AG Company Overview 73
5.31.1 Ganymed Pharmaceuticals AG Pipeline Products & Ongoing Clinical Trials Overview 73
5.32 GeneNews Limited Company Overview 74
5.32.1 GeneNews Limited Pipeline Products & Ongoing Clinical Trials Overview 74
5.33 Georgia Institute of Technology Company Overview 76
5.33.1 Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 76
5.34 GlycoZym Company Overview 78
5.34.1 GlycoZym Pipeline Products & Ongoing Clinical Trials Overview 78
5.35 H. Lee Moffitt Cancer Center & Research Institute, Inc. Company Overview 79
5.35.1 H. Lee Moffitt Cancer Center & Research Institute, Inc. Pipeline Products & Ongoing Clinical Trials Overview 79
5.36 Ikonisys, Inc. Company Overview 80
5.36.1 Ikonisys, Inc. Pipeline Products & Ongoing Clinical Trials Overview 80
5.37 Inanovate (UK) Ltd. Company Overview 81
5.37.1 Inanovate (UK) Ltd. Pipeline Products & Ongoing Clinical Trials Overview 81
5.38 IncellDx, Inc. Company Overview 82
5.38.1 IncellDx, Inc. Pipeline Products & Ongoing Clinical Trials Overview 82
5.39 Innovative Health Diagnostics Company Overview 83
5.39.1 Innovative Health Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 83
5.40 Institut National de la Sante et de la Recherche Medicale Company Overview 84
5.40.1 Institut National de la Sante et de la Recherche Medicale Pipeline Products & Ongoing Clinical Trials Overview 84
5.41 InterGenetics Incorporated Company Overview 85
5.41.1 InterGenetics Incorporated Pipeline Products & Ongoing Clinical Trials Overview 85
5.42 IV Diagnostics, Inc. Company Overview 86
5.42.1 IV Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 86
5.43 KIYATEC Inc. Company Overview 87
5.43.1 KIYATEC Inc. Pipeline Products & Ongoing Clinical Trials Overview 87
5.44 Lab Discoveries Ltd. Company Overview 88
5.44.1 Lab Discoveries Ltd. Pipeline Products & Ongoing Clinical Trials Overview 88
5.45 Laboratorios SALVAT S.A. Company Overview 89
5.45.1 Laboratorios SALVAT S.A. Pipeline Products & Ongoing Clinical Trials Overview 89
5.46 Laboratory Corporation of America Holdings Company Overview 90
5.46.1 Laboratory Corporation of America Holdings Pipeline Products & Ongoing Clinical Trials Overview 90
5.47 Louisville Bioscience, Inc. Company Overview 92
5.47.1 Louisville Bioscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview 92
5.48 MabCure Inc. Company Overview 93
5.48.1 MabCure Inc. Pipeline Products & Ongoing Clinical Trials Overview 93
5.49 Manalto Limited Company Overview 95
5.49.1 Manalto Limited Pipeline Products & Ongoing Clinical Trials Overview 95
5.50 MDNA Life Sciences, Inc. Company Overview 100
5.50.1 MDNA Life Sciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 100
5.51 MDxHealth SA Company Overview 101
5.51.1 MDxHealth SA Pipeline Products & Ongoing Clinical Trials Overview 101
5.52 Metabolon, Inc. Company Overview 103
5.52.1 Metabolon, Inc. Pipeline Products & Ongoing Clinical Trials Overview 103
5.53 Milagen, Inc. Company Overview 104
5.53.1 Milagen, Inc. Pipeline Products & Ongoing Clinical Trials Overview 104
5.54 Myriad Genetics, Inc. Company Overview 105
5.54.1 Myriad Genetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 105
5.55 Nanosphere, Inc. Company Overview 107
5.55.1 Nanosphere, Inc. Pipeline Products & Ongoing Clinical Trials Overview 107
5.56 National University of Singapore Company Overview 109
5.56.1 National University of Singapore Pipeline Products & Ongoing Clinical Trials Overview 109
5.57 Neogenix Oncology, Inc. Company Overview 110
5.57.1 Neogenix Oncology, Inc. Pipeline Products & Ongoing Clinical Trials Overview 110
5.58 Novel Bio-spectrum Technologies, Inc. Company Overview 111
5.58.1 Novel Bio-spectrum Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 111
5.59 NuCana BioMed Limited Company Overview 112
5.59.1 NuCana BioMed Limited Pipeline Products & Ongoing Clinical Trials Overview 112
5.60 Oncgnostics GmbH Company Overview 113
5.60.1 Oncgnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview 113
5.61 Orion Genomics LLC Company Overview 114
5.61.1 Orion Genomics LLC Pipeline Products & Ongoing Clinical Trials Overview 114
5.62 Oryzon Genomics S.A. Company Overview 115
5.62.1 Oryzon Genomics S.A. Pipeline Products & Ongoing Clinical Trials Overview 115
5.63 OTraces Inc. Company Overview 116
5.63.1 OTraces Inc. Pipeline Products & Ongoing Clinical Trials Overview 116
5.64 OvaGene Oncology Inc. Company Overview 117
5.64.1 OvaGene Oncology Inc. Pipeline Products & Ongoing Clinical Trials Overview 117
5.65 PeriRx LLC Company Overview 118
5.65.1 PeriRx LLC Pipeline Products & Ongoing Clinical Trials Overview 118
5.66 Pronota NV Company Overview 119
5.66.1 Pronota NV Pipeline Products & Ongoing Clinical Trials Overview 119
5.67 Protagen AG Company Overview 120
5.67.1 Protagen AG Pipeline Products & Ongoing Clinical Trials Overview 120
5.68 Proteomika Company Overview 121
5.68.1 Proteomika Pipeline Products & Ongoing Clinical Trials Overview 121
5.69 Provista Diagnostics Inc. Company Overview 122
5.69.1 Provista Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview 122
5.70 RCP Diagnostics, LLC (Inactive) Company Overview 123
5.70.1 RCP Diagnostics, LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 123
5.71 RiboMed Biotechnologies, Inc. Company Overview 124
5.71.1 RiboMed Biotechnologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 124
5.72 Rice University Company Overview 125
5.72.1 Rice University Pipeline Products & Ongoing Clinical Trials Overview 125
5.73 Roche Diagnostics International Ltd. Company Overview 127
5.73.1 Roche Diagnostics International Ltd. Pipeline Products & Ongoing Clinical Trials Overview 127
5.74 Rosetta Genomics, Ltd. Company Overview 129
5.74.1 Rosetta Genomics, Ltd. Pipeline Products & Ongoing Clinical Trials Overview 129
5.75 Rush University Medical Center Company Overview 131
5.75.1 Rush University Medical Center Pipeline Products & Ongoing Clinical Trials Overview 131
5.76 SomaLogic, Inc. Company Overview 132
5.76.1 SomaLogic, Inc. Pipeline Products & Ongoing Clinical Trials Overview 132
5.77 Soricimed Biopharma Inc. Company Overview 133
5.77.1 Soricimed Biopharma Inc. Pipeline Products & Ongoing Clinical Trials Overview 133
5.78 Stage I Diagnostics, Inc. Company Overview 135
5.78.1 Stage I Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 135
5.79 SurExam Life Science & Technology Co. Company Overview 136
5.79.1 SurExam Life Science & Technology Co. Pipeline Products & Ongoing Clinical Trials Overview 136
5.80 Target Discovery, Inc. Company Overview 137
5.80.1 Target Discovery, Inc. Pipeline Products & Ongoing Clinical Trials Overview 137
5.81 Teva Pharmaceutical Industries Limited Company Overview 138
5.81.1 Teva Pharmaceutical Industries Limited Pipeline Products & Ongoing Clinical Trials Overview 138
5.82 The Johns Hopkins University Company Overview 140
5.82.1 The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 140
5.83 The University of Adelaide Company Overview 142
5.83.1 The University of Adelaide Pipeline Products & Ongoing Clinical Trials Overview 142
5.84 The University of Texas M. D. Anderson Cancer Center Company Overview 143
5.84.1 The University of Texas M. D. Anderson Cancer Center Pipeline Products & Ongoing Clinical Trials Overview 143
5.85 Todos Medical Company Overview 144
5.85.1 Todos Medical Pipeline Products & Ongoing Clinical Trials Overview 144
5.86 Transbiomed, SL Company Overview 145
5.86.1 Transbiomed, SL Pipeline Products & Ongoing Clinical Trials Overview 145
5.87 Universite de Montreal Company Overview 146
5.87.1 Universite de Montreal Pipeline Products & Ongoing Clinical Trials Overview 146
5.88 University of South Florida Company Overview 148
5.88.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 148
5.89 US Biomarkers, Inc. Company Overview 150
5.89.1 US Biomarkers, Inc. Pipeline Products & Ongoing Clinical Trials Overview 150
5.90 Vermillion, Inc. Company Overview 151
5.90.1 Vermillion, Inc. Pipeline Products & Ongoing Clinical Trials Overview 151
5.91 Vitatex Inc. Company Overview 154
5.91.1 Vitatex Inc. Pipeline Products & Ongoing Clinical Trials Overview 154
5.92 Vitruvian Biomedical, Inc. Company Overview 157
5.92.1 Vitruvian Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 157
5.93 Yale University Company Overview 158
5.93.1 Yale University Pipeline Products & Ongoing Clinical Trials Overview 158
6 Ovarian Cancer- Recent Developments 159
7 Appendix 171
7.1 Methodology 171
7.2 About GlobalData 173
7.3 Contact Us 174
7.4 Disclaimer 174


【レポート販売概要】

■ タイトル:世界における卵巣がん検査製品のパイプライン動向2015
■ 英文:Ovarian Cancer - Pipeline Review, 2015
■ 発行日:2015年10月1日
■ 調査会社:GlobalData
■ 商品コード:GDME0074EPD
■ 調査対象地域:グローバル
  • タイの火力発電市場2016:発電能力、生産、投資動向、制度、企業
    Thermal Power in Thailand, Market Outlook to 2030, Update 2016 - Capacity, Generation, Power Plants, Regulations and Company Profiles Summary "Thermal Power in Thailand, Market Outlook to 2030, Update 2016 - Capacity, Generation, Power Plants, Regulations and Company Profiles” is the latest report from GlobalData, the industry analysis specialists that offer comprehensive information and understan …
  • ビタミン及びプロビタミンのグローバル市場(~2019)
    The industry report Global Vitamin and Provitamin Market to 2019 - Market Size, Development, and Forecasts offers the most up-to-date market data on the actual market situation, and future outlook for vitamins and provitamins in the world. The research includes historic market data from 2008 to 2014 and forecasts until 2019 which makes the report an invaluable resource for industry executives, mar …
  • 北米の患者診察機器市場見通し(~2021)
    North America Patient Examination Devices Market Outlook to 2021 Summary GlobalData’s new report, "North America Patient Examination Devices Market Outlook to 2021", provides key market data on the North America Patient Examination Devices market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Stethoscopes an …
  • モバイルプラットフォームにおけるポータブルアプリケーション(Mobile Applications and Widgets: Portable Applications on Mobile Platforms, Sixth Edition)
    Mobile Applications and Widgets: Portable Applications on Mobile Platforms, Sixth Edition provides a complete understanding of the mobile software marketplace. The reader will learn about mobile applications from the inception and evolution of applications on mobile platforms, to current market trends. The state of the current market is evaluated with reference to current market and data, financia …
  • ブレーキ装置の世界市場:用途(乗用車、商用車、オフハイウェイ車両、ワゴン、機関車、RTV)、種類(ディスクブレーキ、ドラムブレーキ)、技術(ABS、TCS、ESC、EBD)
    Asia-Oceania is estimated to dominate the brake system market for automotive. The growth can be majorly attributed to the increasing demand of vehicles across the region. As of 2015, China and Japan are estimated to lead the brake system market for automotive in the region, whereas the Indian brake system market for automotive is projected to be one of the fastest growing markets. This growth can …
  • アミロイドーシス(Amyloidosis)の治療薬パイプライン動向(2015年上半期版)
    Amyloidosis - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Amyloidosis - Pipeline Review, H1 2015’, provides an overview of the Amyloidosis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Amyloidosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route …
  • ナローバンド(狭帯域)IoTの世界市場予測(~2022年)
    According to the Markets and Markets forecast, narrowband IoT (NB-IoT) market is expected to grow from USD 16.7 Million in 2017 to USD 181.02 Million by 2022, at a CAGR of 61.06% between 2017 and 2022. The increasing adoption of IoT and growth in network-enabled devices, and demand for long-range connectivity is driving the market. The existing LPWA technologies are fragmented, non-standardized, a …
  • トルクセンサの世界市場2016-2020
    About Torque Sensor A torque sensor or a torque transducer is a device that is used for measuring the amount of torque acting upon a rotating system or mechanism in machinery such as engine, transmission, gearbox, crankshaft, or rotor. Torque sensors can measure all the components of torque acting along the six axes of a rotating system. Torque sensors measure both static and dynamic torque. Howev …
  • 特発性肺線維症(Idiopathic Pulmonary Fibrosis):治療薬開発パイプライン動向(2015年上半期版)
    Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2015’, provides an overview of the Idiopathic Pulmonary Fibrosis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Idiopathic Pulmonary Fibrosis, complete with comparative analysis at various stages, t …
  • 通信向けクラウド式課金サービスの世界市場2015-2019
    Technavio market research analyst's estimate, telecom cloud billing services reached a market size of USD 2.3 billion in 2014. The market is dominated by prepaid subscribers with close to 79% of GSM subscribers using these services. Most telecom operators cater to the requirements of this market. Currently, many telecom service providers are adopting a customer-centric business model to increase t …
  • 世界における頭蓋顎顔面固定(CMF)デバイスの製品パイプライン動向2015
    Cranio Maxillofacial Fixation (CMF) - Pipeline Review, 2015 Summary GlobalData's Medical Devices sector report, “Cranio Maxillofacial Fixation (CMF) - Pipeline Review, 2015" provides an overview of Cranio Maxillofacial Fixation currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of developme …
  • ポリスチレン(PS)の世界市場予測
    Plystyrene 2014 World Market Outlook and Forecast is an absolutely essential resource for anyone looking for detailed information on the mentioned market. Using a wide range of primary and secondary sources, we combined, analyzed and presented all available data about plystyrene market in the all-in-one report issued in a logical and easily accessible format. In addition to the analytical part, th …
  • 落書き防止用塗料の世界市場2019-2023
    Global Anti-graffiti Coatings Market: About this market Anti-graffiti coatings are special-purpose coatings to prevent cases of graffiti vandalism. Technavio’s Anti-graffiti coatings market analysis considers sales to the construction and transportation segments. Our analysis also considers the sales of anti-graffiti coatings in APAC, Europe, MEA, North America, and South America. In 2018, the con …
  • 主要先進国における胃腸治療薬市場(~2019)
    Gastrointestinal Therapeutics in Major Developed Markets to 2019 - New Drug Approvals and Promising Pipeline to Counter Declines from Patent Expiries Summary GBI Research, the leading business intelligence provider, has released its latest research, ‘Gastrointestinal Therapeutics in Major Developed Markets to 2019 - New Drug Approvals and Promising Pipeline to Counter Declines from Patent Expiries …
  • Respiratory Syncytial Virus:医療検査市場2014
    The report presents a detailed analysis of the Respiratory Syncytial Virus diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Respiratory Syncytial Virus definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments:      …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。